Blog

MicroSalt plc (LSE: SALT) revealed additional payments totaling around USD 330,000 to Tekcapital plc and its subsidiaries, which were identified as an unreported related party transaction. These payments, made between July and September 2024, were not contractually obligated at the time and were omitted from disclosures as required by AIM Rule 13.

Following a thorough investigation led by Independent Directors chaired by Judith Batchelar, enhanced controls and systems have been implemented to prevent future occurrences. The investigation confirmed that the payments were legitimate liabilities and accurately reflected in the company’s financial statements.

Despite some positive corporate actions, MicroSalt’s outlook remains challenged by weak financial performance, negative equity, and ongoing losses. Technical indicators show bearish trends, with the stock currently oversold.

About MicroSalt plc

MicroSalt plc is a food industry leader specializing in producing full-flavor salt containing approximately 50% less sodium, aiming to offer healthier salt alternatives to consumers.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Belluscura PLC (LSE:BELL) has terminated a $1.5 million Loan Note arrangement with Omaha Value, Inc following a failure to receive the agreed funds, leading to the cancellation of associated warrants. The company is currently reviewing strategic alternatives to maximize stakeholder value, including the possibility of selling key assets and intellectual property to a U.S.-based medical device firm.

This potential transaction is under a 15-day exclusivity period for due diligence. Meanwhile, Belluscura’s shares remain suspended as the company continues discussions on funding and delays the completion of its 2024 Annual Report.

About Belluscura PLC

Belluscura PLC is a UK medical device company focused on developing oxygen enrichment technologies for various industrial and therapeutic uses.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Bluebird Mining Ventures Ltd (LSE:BMV) has outlined a revised strategic direction, combining its gold development activities with a new focus on Bitcoin as part of its asset base. As part of the shift, Sath Ganesarajah has been appointed Chief Executive Officer to guide the company through this transformation, which includes acquiring Bitcoin assets and pursuing strategic transactions.

The company plans to raise at least £10 million and anticipates completing its first Bitcoin streaming deal in the near term. Management says the goal is to position Bluebird as a disciplined, asset-backed public company that blends gold development with strategic treasury management to maximize long-term value.

About Bluebird Mining Ventures

Bluebird Mining Ventures Ltd is a gold-focused development company committed to advancing its project portfolio and increasing shareholder returns. The company is expanding its strategy to incorporate Bitcoin into its treasury, treating it as a digital reserve asset comparable to “digital gold.”

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Diversified Energy Company (LSE:DEC) reported a solid performance for the second quarter of 2025, underpinned by strong cash flow and effective integration of its Maverick acquisition. The company generated notable returns through its portfolio optimization initiatives and strategic alliances, including a $2 billion commitment from The Carlyle Group. This collaboration is designed to capitalize on industry consolidation, reinforcing Diversified’s role as a leading acquirer of upstream proved developed producing (PDP) assets.

Ongoing asset optimization efforts added $70 million in extra cash flow, while the company maintained a robust balance sheet and delivered substantial returns to shareholders. With market drivers such as electrification and U.S. LNG export growth, Diversified sees itself well-positioned to prosper in a shifting energy environment.

The company’s outlook is supported by strong strategic execution, debt reduction, and share buyback programs, though high leverage and negative earnings continue to weigh on its valuation.

About Diversified Energy Company

Diversified Energy Company PLC specializes in acquiring and managing mature oil and gas assets, with a focus on maximizing cash flow and creating shareholder value. Its strategy centers on U.S.-based PDP assets, complemented by strategic partnerships and disciplined capital management.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Chill Brands Group plc (LSE:CHLL) has regained its listing on the London Stock Exchange after a suspension in June 2024 caused by delays in financial reporting. With audits now complete, the company is concentrating on the growth of its Chill Connect division, which provides distribution services to FMCG brands. This unit is leveraging the UK’s ban on disposable vapes to meet increasing demand for reusable alternatives in the tobacco-free market.

In addition, Chill Brands is enhancing its e-commerce platform, Chill.com, to broaden its marketplace offering. The company’s financial position is bolstered by recent fundraising efforts and expected VAT rebates, positioning it for expansion. However, management acknowledges that further capital may be needed to support revenue-generating initiatives.

About Chill Brands Group

Chill Brands Group plc is a distribution-focused consumer packaged goods business that brings innovative fast-moving consumer products to market. Its portfolio spans tobacco alternatives, functional beverages, and other novel goods, with a particular emphasis on the convenience store sector. The company partners with both established FMCG players and emerging high-growth brands, while also operating Chill.com, an e-commerce marketplace showcasing third-party products.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Anglo-Eastern Plantations (LSE:AEP) delivered strong financial results for the first half of 2025, with revenue climbing 39% and profit before tax rising 78%. The growth was driven by increased sales volumes and higher prices for both crude palm oil (CPO) and palm kernel.

The company’s balance sheet remains robust, supported by substantial cash reserves and zero bank debt. Alongside the results, Anglo-Eastern announced a £8 million share buyback program. Looking ahead, the outlook remains upbeat, with CPO prices expected to stay firm, supported by rising demand from India and Indonesia as well as geopolitical factors shaping the global vegetable oil market.

Financial indicators reflect the company’s strong profitability and low leverage, creating a solid base for growth. While technical analysis points to bullish momentum, analysts note the potential for overbought conditions. Attractive valuation metrics further enhance investor appeal.

About Anglo-Eastern Plantations

Anglo-Eastern Plantations Plc is engaged in the ownership, operation, and development of agricultural plantations in Indonesia and Malaysia. The company primarily produces crude palm oil and palm kernel to meet growing global demand for vegetable oils.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Dekel Agri-Vision (LSE:DKL) reported a mixed operational performance for July 2025, with crude palm oil production declining sharply year-on-year due to an earlier-than-usual start to the low season. However, crude palm oil prices rose 22.4%, bringing local market prices in line with global levels.

In contrast, the company’s cashew processing division delivered a record month, with raw cashew nut throughput surging 423% compared to July 2024. New processing equipment, expected to arrive shortly, is anticipated to further boost capacity and support the company’s goal of achieving its first EBITDA-positive year.

While Dekel Agri-Vision’s valuation remains pressured by weak financial results and technical indicators, recent operational milestones and strategic actions provide some grounds for optimism.

About Dekel Agri-Vision

Dekel Agri-Vision Plc is a diversified agriculture company operating in West Africa. Its portfolio in Côte d’Ivoire includes a fully operational palm oil facility in Ayenouan and a cashew processing plant in Tiebissou, which is currently ramping up to full-scale commercial production.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

GSK (LSE:GSK) has announced that the U.S. Food and Drug Administration has granted priority review status to gepotidacin, an oral therapy for uncomplicated urogenital gonorrhoea. A regulatory decision is anticipated in December 2025. If approved, this novel antibiotic could replace current injectable treatments, addressing a critical public health challenge as resistance to existing therapies continues to rise for this priority pathogen.

GSK’s broader outlook reflects solid financial results and strategic initiatives, including share repurchase programs and acquisitions aimed at boosting shareholder returns. Technical signals currently indicate a neutral market view, with the company’s valuation considered fair and supported by an appealing dividend yield. Recent earnings calls emphasized growth in specialty medicines, alongside noted headwinds in vaccine sales and evolving regulatory requirements.

About GSK

GSK is a global biopharmaceutical leader committed to advancing prevention and treatment through the integration of science, technology, and expertise. With more than seven decades of innovation in infectious diseases, the company maintains a diverse portfolio of medicines and vaccines designed to address unmet medical needs and combat antimicrobial resistance.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Asiamet Resources Limited (LSE:ARS) has appointed Peter Oliver as Project Director for the first stage of its BKM Copper Project in Central Kalimantan, Indonesia. Bringing more than three decades of experience in delivering projects across the mining, energy, and infrastructure sectors, Oliver will oversee the transition from financing to construction. His leadership is expected to bolster the company’s execution capabilities and foster stronger relationships with stakeholders.

This strategic move is aimed at reinforcing Asiamet’s industry standing by ensuring the project adheres to international best practices, a step that could attract additional funding and strategic partnerships.

About Asiamet Resources

Asiamet Resources Limited is a mining company focused on copper development. Its flagship asset is the BKM Copper Project in Central Kalimantan, Indonesia, operated through its subsidiary, PT Kalimantan Surya Kencana.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Falcon Oil & Gas Ltd (LSE:FOG) has reported a record-breaking 90-day initial production flow rate from its Shenandoah South 2H Sidetrack well in Australia’s Beetaloo Sub-basin, averaging 6.7 million cubic feet of gas per day. The strong performance underscores the region’s commercial viability, with gas sales to the Northern Territory Government expected to begin by mid-2026.

The company’s current drilling campaign is advancing without any cost exposure for Falcon Australia during this phase, a factor that could strengthen its market position and deliver increased value for stakeholders.

About Falcon Oil & Gas

Falcon Oil & Gas Ltd is a global oil and gas exploration and development company focused on unconventional resource plays, particularly in Australia. Incorporated in British Columbia, Canada, and headquartered in Dublin, Ireland, the company operates through key subsidiaries, including Falcon Oil & Gas Australia Limited.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.